Cargando…

Amphotericin B cement beads: A good adjunctive treatment for musculoskeletal mucormycosis

Mucormycosis is one among the aggressive, invasive fungal infections usually seen in immunocompromised patients. Mucormycosis osteomyelitis is very rare. We present a patient with acute myeloid leukemia who complained of pain over the right proximal thigh. Plain radiograph revealed ill defined osteo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arockiaraj, Justin, Balaji, Gopisankar, Ashok, Anand, Kokil, Gautami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377153/ https://www.ncbi.nlm.nih.gov/pubmed/22719129 http://dx.doi.org/10.4103/0019-5413.96370

Ejemplares similares

Isolated Tubercular Osteomyelitis of Scapula – A Report of Two Cases and Review of Literature
por: Balaji, Gopisankar, et al.
Publicado: (2013)

Combination of amphotericin B and caspofungin in the treatment of mucormycosis
por: Gargouri, Marwa, et al.
Publicado: (2019)

Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis
por: Singh, Prabhakar, et al.
Publicado: (2022)

Successful treatment of cutaneous mucormycosis disseminated from pulmonary mucormycosis with liposomal amphotericin B and posaconazole
por: Ding, Xiao-Lan, et al.
Publicado: (2020)

Bronchoscopic instillation of liposomal amphotericin B in management of nonresponding endobronchial mucormycosis
por: Nattusamy, Loganathan, et al.
Publicado: (2017)

1554. Nebulized Liposomal Amphotericin B for Treatment of Murine Pulmonary Mucormycosis
por: Sandoval, Adilene, et al.
Publicado: (2019)

Sinonasal mucormycosis and liposomal amphotericin B: A quest for dose optimization
por: Kajal, Smile, et al.
Publicado: (2022)

Successful Treatment of Mucormycosis Caused by Rhizopus arrhizus With Amphotericin B and Itraconazole
por: Cham, Chen Yi, et al.
Publicado: (2023)

Amphotericin B colloidal dispersion: an effective drug for the treatment of mucormycosis in China
por: Liu, Juntao, et al.
Publicado: (2023)

Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2021)

745. Combination Treatment of Liposomal Amphotericin B and Isavuconazole is Synergistic in Treating Experimental Mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2020)

Long-term outcomes of transcutaneous retrobulbar amphotericin B in COVID-19-associated mucormycosis
por: Rizvi, Syed Wajahat A, et al.
Publicado: (2023)

Rhino-oculo Cerebral Mucormycosis Resistant to Amphotericin B in a Young Patient with Diabetic Ketoacidosis
por: Ali Asghar, Sarrah, et al.
Publicado: (2019)

Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B
por: Safi, Mustafa, et al.
Publicado: (2020)

Amphotericin-B liposomal /mycophenolic acid/tacrolimus: Mucormycosis and lack of efficacy: 2 case reports
Publicado: (2021)

Amphotericin-b/dexamethasone/voriconazole: Palatal mucormycosis, neutropenia and electrolyte disturbance: 2 case reports
Publicado: (2022)

Adjunctive use of saturated solution of potassium iodide (SSKI) with liposomal amphotericin B (L-AMB) in mucormycosis achieves favorable response, shortened dose and duration of amphotericin: A retrospective study from a COVID-19 tertiary care center
por: Mrig, Sumit, et al.
Publicado: (2022)

Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report
por: Çagatay, Atahan A, et al.
Publicado: (2001)

Amphotericin-b/dexamethasone/tocilizumab: Bronchopleural fistula, Rhizopus-associated mucormycosis and lack of efficacy: case report
Publicado: (2020)

Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis
por: Murthy, Ramesh, et al.
Publicado: (2022)

Use of topical amphotericin in a case of refractory sino-orbital angioinvasive mucormycosis
por: Beaver, Ryan, et al.
Publicado: (2021)

Fungal Endophthalmitis in a Case of Rhino-Orbito-Cerebral Mucormycosis: Successfully Treated With Amphotericin B Colloidal Dispersion
por: Zhao, Yinlong, et al.
Publicado: (2022)

845. Clinical Outcomes in Patients Treated with High vs. Standard Dose Liposomal Amphotericin B for Invasive Mucormycosis
por: Valiante, Sarah, et al.
Publicado: (2023)

Outcomes of Transcutaneous Retrobulbar Amphotericin B in Rhino-Orbital-Cerebral Mucormycosis Among Patients Recovering From COVID-19: A Preliminary Experience
por: Sinha, Shivani, et al.
Publicado: (2022)

Cement beads and cement spacers: indications, techniques, and clinical results
por: Kulkarni, Govind Shivram, et al.
Publicado: (2021)

Retrospective analysis of the role of retrobulbar amphotericin-B injection in the management of COVID-19 associated rhino-orbito-cerebral-mucormycosis
por: Yadav, Rekha, et al.
Publicado: (2022)

Mucormycosis in a Severe Trauma Patient Treated with a Combination of Systemic Posaconazole and Topical Amphotericin B—Case Report
por: Keller, Filip, et al.
Publicado: (2023)

An Amphotericin B Derivative Equally Potent to Amphotericin B and with Increased Safety
por: Antillón, Armando, et al.
Publicado: (2016)

Encochleated Amphotericin B: Is the Oral Availability of Amphotericin B Finally Reached?
por: Aigner, Maria, et al.
Publicado: (2020)

WCN23-0704 Liposomal amphotericin associated nephrotoxicity in patients with Mucormycosis: An epidemic in the midst of Pandemic
por: KISHAN, A., et al.
Publicado: (2023)

Proven invasive pulmonary mucormycosis successfully treated with amphotericin B and surgery in patient with acute myeloblastic leukemia: a case report
por: Vidovic, Ana, et al.
Publicado: (2013)

Successful treatment of rhinoorbital mucormycosis due to Rhizopus arrhizus with liposomal amphotericin B, posaconazole and surgical debridement in a child with neuroblastoma
por: Athanasiadou, Kleoniki I., et al.
Publicado: (2019)

Desensitization to liposomal amphotericin B after anaphylaxis in a patient with COVID-19-associated mucormycosis – A case with review of literature
por: Swain, Satish, et al.
Publicado: (2022)

Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience
por: Ramamurthy, Lakshmi B, et al.
Publicado: (2022)

Retrobulbar Amphotericin B Injection in Curbing the Progression of COVID Associated Rhino-orbital Cerebral Mucormycosis: A Retrospective Case Series
por: Pathak, Madhumallika, et al.
Publicado: (2022)

Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19
por: Shakrawal, Jyoti, et al.
Publicado: (2022)

LB1580. Efficacy Assessment of MAT2203 Encochleated Oral Formulation of Amphotericin B, in the Neutropenic Mouse Model of Pulmonary Mucormycosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2022)

Pharmacovigilance study of amphotericin B for mucormycosis in post-COVID and non-COVID patients at a tertiary care hospital in Eastern India
por: Chatterjee, Suparna, et al.
Publicado: (2022)

Amphotericin-B in Dermatology
por: Agarwal, Akash, et al.
Publicado: (2022)

Amphotericin-B/amphotericin-B-liposomal: Lack of efficacy: 2 case reports
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_udcpkkl6m4dqjpebvi3aa5vcht